NanoGhost
Targeted Drug Delivery Platform | Home
Netanya, Israel · $9.0M raised
- Headquarters
- Netanya
- Business Model
- B2B
- Website
- nano-ghost.com
- Total Funding
- $9.0M
- Last Round
- $4.0M Venture RoundAug 2023
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
NanoGhost develops a first-in-class drug targeting platform using cell membranes of mesenchymal cells for selective tumor and inflammation targeting.
Summary
NanoGhost is a Biotech company based in Netanya, Israel. It has raised $9.0M in total across 2 rounds, most recently a $4.0M Venture Round in Aug 2023. Investors include aMoon and Mission BioCapital.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Aug 2023
Sign up to see all 2 events
Funding: Seed through Venture Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/nanoghost"><img src="https://indexed.vc/api/badge/company/nanoghost" alt="NanoGhost on Indexed.vc" width="260" height="76" /></a>